Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy.

Front Immunol · 2020 · PMC7362897 · PMID 32733447

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

This factor may not be significant in human disease, where the clinical observation of prostate cancer often finds slow growth and progression; (4) insufficient impact of targeting a single epitope.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.